Evogene Ltd. — Form SCHEDULE 13D/A
Filed October 6, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D/A
— Neutral
significance 52/100
What the filing says
L.I.A. Pure Capital Ltd. (2,557,488 shares, 14.16%) and Invest Pro Shukai Hon Ltd. (500,000 shares, 2.76%) together holding 16.93% of Evogene Ltd. executed a cooperation agreement dated October 6, 2026, resolving their demand for director removal. Two departing directors resigned; two initial shareholder-nominated directors were appointed; two additional shareholder directors will stand for election at a general meeting (within 42 days). Three incumbent directors remain for a six-month transition. The shareholders withdrew a threatened special tender offer and agreed to a 60-day standstill. Mutual releases and non-disparagement covenants concluded the dispute.
Why this rating
Significant proxy contest resolved via board compromise; 4-of-7 seats granted to 16.93% holders. No financial transaction disclosed. Impact neutral—dispute settled, but outcome uncertain pending shareholder vote and transition execution.
See more from October 6, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.